Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( (AU:IMR) ) has shared an update.
Imricor Medical Systems, Inc. announced that Semmelweis University in Budapest, Hungary, has become the first hospital in the country to perform atrial flutter ablations using Imricor’s real-time MRI-guided technology. This marks a significant expansion of Imricor’s presence in Europe, with the company aiming to enhance patient outcomes and reduce procedure times without the use of ionizing radiation. The development aligns with Imricor’s mission to expand its installed base across Europe and add more sites to its VISABL-VT trial, showcasing the potential of MRI-guided procedures in improving cardiac care.
More about Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
Imricor Medical Systems, Inc. is a leader in developing MRI-compatible products for cardiac catheter ablation procedures. The company aims to enhance interventional medical procedures by utilizing real-time MRI guidance instead of traditional x-ray fluoroscopy, leveraging MRI’s superior imaging capabilities. Imricor’s flagship product, the Vision-MR Ablation Catheter, is designed to improve success rates and safety in cardiac procedures. The company has secured approvals in the EU, Saudi Arabia, and New Zealand, and is pursuing further regulatory approvals in the U.S. and other regions.
YTD Price Performance: 16.54%
Average Trading Volume: 391,752
Find detailed analytics on IMR stock on TipRanks’ Stock Analysis page.